Viewing Study NCT03963206


Ignite Creation Date: 2025-12-26 @ 2:40 PM
Ignite Modification Date: 2026-01-20 @ 3:38 PM
Study NCT ID: NCT03963206
Status: COMPLETED
Last Update Posted: 2025-12-01
First Post: 2019-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE)
Sponsor: Hospices Civils de Lyon
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular carcinoma View
None Cabozantinib View